Uwamino, Yoshifumi
Nishimura, Tomoyasu
Sato, Yasunori
Tamizu, Eiko
Asakura, Takanori
Uno, Shunsuke
Mori, Masaaki
Fujiwara, Hiroshi
Ishii, Makoto
Kawabe, Hiroshi
Murata, Mitsuru
Hasegawa, Naoki
Funding for this research was provided by:
the Japan Society for the Promotion of Science (KAKENHI grant: 16K19618 and 18K16186)
Asteras Pharmaceutical Co. Ltd (N/A)
Article History
Received: 27 June 2019
Accepted: 29 November 2019
First Online: 16 December 2019
Change Date: 12 February 2020
Change Type: Correction
Change Details: After publication of the original article [1], we were notified that units of testosterone in main text and abstract and units of DHEA-S in Fig. 1 and Table 4 are incorrect.
Ethics approval and consent to participate
: The study comparing MAC-LD patients with healthy controls was approved by the ethics committee at Keio University (No. 15–007) and the ethical committee of Keio University School of Medicine (No. 20150420). All participants provided written informed consent. The study comparing pooled samples of MAC-LD patients with those of non-NTM BE patients was approved by the ethical committee of Keio University School of Medicine (No. 20180261). All patients provided written informed consent when samples were originally obtained.
: Not applicable.
: The authors declare that they have no competing interests.